KATHERINE WILLIAMS: Open Payments
NPI 1134471485 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 56 payments from 17 companies in 2025. Trend: 2023 $1,439 · 2024 $1,157 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $202 |
| Lilly USA, LLC | 10 | $157 |
| PFIZER INC. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Astellas Pharma US Inc | 3 | $64 |
| Corcept Therapeutics | 2 | $43 |
| Abbott Laboratories | 2 | $41 |
| Novo Nordisk Inc | 2 | $38 |
| Boston Scientific Corporation | 1 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: MOUNJARO, UBRELVY, Veozah, Korlym, FREESTYLE LIBRE 3, NURTEC ODT, JARDIANCE, General - Pain Management.
Industry payments across GA — which companies pay providers there.
